• Home
  • Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).

Author List
Rao VK, Price S, Perkins K, Aldridge P, Tretler J, Davis J, Dale JK, Gill F, Hartman KR, Stork LC, Gnarra DJ, Krishnamurti L, Newburger PE, Puck J, Fleisher T
Publication
Pediatric blood & cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1466626
Publication Year
2009
PubMed ID
19214977
Publication Title
Rao VK, Price S, Perkins K, Aldridge P, Tretler J, Davis J, Dale JK, Gill F, Hartman KR, Stork LC, Gnarra DJ, Krishnamurti L, Newburger PE, Puck J, Fleisher T. Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS). Pediatr Blood Cancer. 2009 Jul; 52(7):847-52.